Firefly BioWorks

Firefly BioWorks (Cambridge, MA) is launching an open platform that allows industrial, academic, and clinical scientists to develop and utilize multiplex bioassays on standard laboratory instruments. The company’s core technology, Optical Liquid Stamping, was developed by Firefly’s co-founders in the Department of Chemical Engineering at MIT (News - Alert). This method enables rapid and scalable synthesis of encoded multifunctional particles for quantifying biological functions. The company’s long-term vision is to provide research and clinical scientists with reliable and cost-effective solutions for comprehensive monitoring of biological systems.